We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Will Widen Expanded Access Tool to Cover Orphan Drugs
FDA Will Widen Expanded Access Tool to Cover Orphan Drugs
Writing in an FDA blog post, Commissioner Scott Gottlieb said the agency will broaden the scope of its Expanded Access Navigator tool — an information resource created by the Reagan-Udall Foundation to speed up pre-approval access to drugs.